There are limited reports on the relationship between mucin 5AC (MUC5AC) concentrations in tears, working hours, and the frequency of ocular symptoms in visual display terminal (VDT) users. This investigation evaluated these relationships among patients with dry eye disease (DED) and individuals serving as controls.
R ecent years have seen widespread use of personal computers and portable information terminals and a dramatic increase in the amount of work done using visual display terminals (VDTs). The number of people using VDTs increases globally with growing use of the Internet. In 2012, the number of Internet users worldwide was 2.4 billion, almost twice the value reported 5 years earlier. 1 In Japan, approximately 95 million people (80% of the Japanese population) were using the Internet by the end of 2010. 2 Prolonged VDT work has been reported to cause general and musculoskeletal symptoms, such as physical fatigue and back pain, as well as pain in the shoulders and wrists. 3, 4 Furthermore, VDT work has been reported [5] [6] [7] to cause ocular symptoms including asthenopia, reduced visual acuity, ocular pain, and dry eyes resulting from increased tear evaporation, decreased rate of blinking, and reduced tear secretion. In other epidemiologic studies 8, 9 using a questionnaire, longer duration of VDT use was associated with a significant trend toward a higher prevalence of dry eye symptoms and clinically diagnosed dry eye disease (DED). The pathogenesis of DED symptoms in VDT users may be due to changes in the composition of the tear film; however, it is unclear. Basic research 10 data suggest that the aqueous layer of the tear film is composed of mucins dissolved in the lacrimal fluid and that there is not a distinct mucin layer within the tears. The mucin in tear mucin 5AC (MUC5AC) is secreted by goblet cells in the conjunctiva. 11 A large gelforming mucin with extensive O-glycosylation, MUC5AC plays an important role in epithelial surface protection by clearing the ocular surface of debris. 12 The decrease in MUC5AC concentration in ocular surface abnormalities may impair the wettability of the epithelium because the hydrophilic nature of the secreted mucins, which results from their heavy glycosylation, helps to hold fluids on epithelial surfaces. 13 Data obtained via enzyme-linked immunosorbent assay have shown that the MUC5AC concentration is significantly lower in the tear fluid of patients with Sjögren syndrome than in healthy individuals. 14 Although it has been reported 8, 9 that prolonged use of VDTs is a risk factor for DED and that MUC5AC is significantly decreased in the tears of patients with DED, there are no reports evaluating alterations of MUC5AC in the tears of VDTs users. The aim of the present combined public health-and clinicalbased study was to determine the relationships between tear MUC5AC concentration in VDT users and (1) the severity of DED, (2) the number of VDT working hours, and (3) the frequency of ocular symptoms.
Methods

Participant Selection
This research followed the tenets of the Declaration of Helsinki, and the protocol of this institutional and crosssectional study was approved by the institutional review board of Ryogoku Eye Clinic, Tokyo, Japan. Written informed consent was received from all participants before study initiation. The participants did not receive financial compensation.
Under the supervision of the Japanese Dry Eye Society, we arbitrarily selected 2 large companies listed in the Japanese stock market and sent a letter to the industrial physicians in the health management section of each company explaining the purpose of the study and requesting their participation. The first company in the pharmaceutical sector that responded to our letter and consented to participate was enrolled in this study. The participant company was Osaka based; hence, the present study was named The Osaka Study. Participants included 96 individuals of a total of 561 who volunteered to provide impression cytology samples for The Osaka Study.
Questionnaire
We administered a questionnaire regarding DED that is widely used in Japan. 15 In brief, the questionnaire included 12 questions pertaining to the symptoms of DED. 
MUC5AC Concentration in Tears
The concentration of the secreted mucin MUC5AC in the tear samples was quantified by enzyme-linked immunoassay (E90756Hu; USCN Life Science). 22 All samples were analyzed according to the manufacturer's guidelines. Absorbance was measured at 450 nm, and the standard solutions in the kit were recombinant human MUC5AC. A protein assay reagent kit (BCA Protein Assay Kit; Pierce) was used to determine the protein concentration in the tear samples. The MUC5AC concentration was normalized to the tear protein content and expressed as MUC5AC protein (nanograms) per tear total protein (milligrams).
RNA Isolation and Reverse Transcription
Total RNA was isolated from the impression cytology samples using an extraction kit (RNeasy Mini Kit; Qiagen). The homogenization step was skipped because of the small number of cells, and all RNA extraction procedures followed the manufacturer's instructions with an additional DNase I digestion step. 21, 23 Total RNA was used for complementary DNA synthesis (ReverTra Ace-α-; Toyobo) as described in the manufacturer's protocol. Reverse transcription was performed by incubating the tubes at 30°C for 10 minutes, 42°C for 20 minutes, 99°C for 5 minutes, and 4°C for 5 minutes. The reverse transcription products were then ready for use in real-time polymerase chain reaction (PCR). 24 A total of 2 μL of the total reverse transcription volume was used for quantitative real-time PCR.
Quantitative Duplex Real-Time PCR
Quantitative duplex real-time PCR (StepOnePlus; Applied Biosystems) was performed and multiplex PCR reactions were evaluated (TaqMan Gene Expression Master Mix, and TaqMan gene expression assays GAPDH [Hs99999905_m1] and MUC5AC [Hs00873651_mH]; Applied Biosystems) according to the manufacturer's instructions. The following thermocycling conditions were used under standard mode as per manufacturers' recommendations: 20 seconds at 95°C, followed by 40 cycles at 94°C for 1 second and 60°C for 20 seconds. Analysis and fold-change differences were determined by the comparative threshold cycle (CT) method, calculated from the ΔΔCT values using the formula 2 −ΔΔCT . The MUC5AC transcript levels were normalized to a glyceraldehyde-3-phosphate dehydrogenase endogenous control. We used a human reference complementary DNA (Clontech Laboratories) as a calibrator to provide standardization across the PCR plates. 25 The relative quantification was determined by using the standard curve method.
Statistical Analysis
All data are presented as mean (SD). The prevalence of DED was calculated by sex, and the binomial distribution was used to estimate the corresponding 95% CIs. Depending on distribution of individual data, the significance of differences in mean MUC5AC concentration (nanograms per milligram) between groups was determined by the Steel test, the KruskalWallis test, or the Wilcoxon rank sum test, and 95% CI was based on nonparametric Hodges-Lehmann estimates for the difference between 3 groups with a DED diagnosis, between 3 VDT working hours groups, or between symptomatic and asymptomatic groups. P values were determined using the Fisher exact test, an unpaired 2-tailed t test, the Steel test, the Kruskal-Wallis test, or the Wilcoxon rank sum test. All statistical analyses were performed using SAS, version 9.2 (SAS Institute Inc).
Results
Characteristics of the Population
The participant characteristics and demographic data are reported in Table 1 . The 96 individuals who volunteered for tear and impression cytology sampling included 60 men and 36 women aged 22 to 62 years. The mean age was 41.7 (9.8) years for all participants, with 44.3 (10.0) years for men and 37.4 (7.6) years for women. Participants between 30 and 49 years made up 61% of the total study population. The mean duration of VDT use was 8.2 (1.9) hours per day for all participants, with 7.7 (1.9) for men and 9.0 (1.6) for women.
DED Diagnosis
The ocular surface findings and prevalence of DED are reported in Table 2 and , respectively). The proportion of women (13.9%) with definite DED was 2 times greater than that of men (6.7%) and accounted for 9.4% of the study population. The proportion of men and women with probable DED was similar (53.3% and 63.9%, respectively) and accounted for 57.3% of the study population. There were no statistically significant differences in any of the test results (Schirmer test I, TBUT, and fluorescein and lissamine green staining scores) and DED prevalence between men and women.
MUC5AC Concentration in Tears
The mean concentration of MUC5AC, normalized to the total amount of protein in tears, was 6.8 (7.5) ng/mg in 192 eyes. The mean MUC5AC concentration was 6.9 (7.8) ng/mg in men (n = 120) and 6.7 (7.3) ng/mg in women (n = 72). There was no significant difference in mean MUC5AC concentration between men and women (P = .83).
The mean tear MUC5AC concentrations and their relationship to DED diagnosis and VDT use are reported in The relationship between MUC5AC concentration and ocular symptom frequency is reported in Table 5 . According to our classification of DED symptom frequency, we found that the mean MUC5AC concentration was lower in the eye strain symptomatic group (5.1 [5.6] ng/mg; 86 eyes) than in the asymptomatic group (8.2 [9.4] ; 106 eyes) (Wilcoxon rank sum test; P = .001), as well as lower in the excess tearing symptomatic group (3.4 [2.4]; 14 eyes) than in the asymptomatic group (7.1 [8.3] ; 178 eyes) (Wilcoxon rank sum test; P = .04). The estimated differences in eye strain and excess tearing were −1.71 (95% CI, −2.86 to −0.63) and −1.58 (95% CI, −3.63 to −0.09), respectively. Regarding the dry sensation, the symptomatic group tended to have a lower MUC5AC concentration compared with the asymptomatic group (Wilcoxon rank sum test; P = .08). There were no significant MUC5AC concentration differences in relationship to the frequencies of other ocular symptoms between the symptomatic and asymptomatic groups.
Conjunctival MUC5AC Messenger RNA Expression
The normalized level of MUC5AC messenger RNA (mRNA) expression in the conjunctiva of all participants with a sufficient amount for analysis was 1.00 (1.76) (187 eyes). There were no significant differences in conjunctival MUC5AC expression of participants with definite DED (1.03 [ 
Discussion
Dry eye disease is an important public health problem that causes ocular discomfort, fatigue, and visual disturbances that may interfere with daily activities. 26 On the basis of data from the largest epidemiologic studies concerning DED, 27 includ- (20) 1 (3) 13 (14) 5 to <6 12 (20) 5 (14) 17 (18) 6 to <7 6 (10) 11 (31) 17 (18) 7 to <8 14 (23) 5 (14) 19 (20) 8 to <9 7 (18) 7 (19) 14 (14) 9 to <10 0 3 (8)
Contact lens use 13 (22) of millions of individuals have severe symptoms and probably a more episodic manifestation of the disease because of exposure to contributing factors such as VDTs. That questionnaire-based study reported that continuous exposure of office workers to VDTs for long periods of time is a risk factor for the development of DED; however, the investigators did not evaluate the relationship of subjective and objective tests of DED to changes in the molecular composition of the tear film in VDT users. In the present institutional study, we investigated the correlation between the duration of VDT work, the presence of symptoms and signs of DED, and the concentration of MUC5AC of office workers. Mucins are heavily glycosylated glycoproteins, with carbohydrates composing 50% to 80% of their mass. A large gel- forming mucin, MUC5AC is secreted by goblet cells in the conjunctiva, 11, 29 moving throughout the tear film to flush out particulate matter through eyelid movement. The decrease in MUC5AC concentrations may impair the wettability of the ocular surface epithelium because of the hydrophilic nature of the secreted mucins, which results from the heavy glycosylation that helps to hold fluid on epithelial surfaces. 13 In the present study, we report data indicating that a decrease in the MUC5AC concentration in tears may be one of the reasons why VDT users develop DED. First, we used the latest Japanese criteria for DED to categorize the participants and found a decrease in MUC5AC concentration in the tears of the definite DED group compared with the tears of the no DED group. A previous study 14 found a decrease in the goblet cellspecific MUC5AC concentration in the tear fluid of patients with
Sjögren syndrome who had symptoms of DED. In our study, participants in the definite DED group had severe symptoms of DED with clinical alterations of the ocular surface. Our study found a decreased MUC5AC concentration in the tear fluid of VDT users with definite DED who did not have severe hyperemia and epithelial disorders of the ocular surface. Second, we found a correlation between low MUC5AC concentration and prolonged VDT working hours. The use of VDTs is associated with a decreased frequency of blinking, 30 excess evaporation of tear fluid, 5 and hypofunction of the lacrimal glands, 6 each of which can contribute to the pathogenesis of DED. Prolonged VDT use induces a decrease in tear secretion from the lacrimal glands 6 ; however, it remains unknown whether the prolonged use induces a decrease in MUC5AC secretion from goblet cells in the human conjunctiva. Our data indicate that els are significantly reduced in patients with moderate to severe DED. Because most of the definite DED in the present study was mild, we hypothesize that the difference in DED severity between the 2 studies accounts for the discrepancy in MUC5AC mRNA expression. Future research into the detailed mechanisms of MUC5AC regulation and secretion should help to elucidate the relationship between prolonged VDT use and decreased MUC5AC secretion. Tear MUC5AC is primarily responsible for the rheologic properties of mucus secretions because of its hydrophilic character (which results from its heavy glycosylation) that helps hold fluid and lubricate the epithelial surface. 31, 32 We hypothesize that decreased tear MUC5AC concentrations in VDT users may easily be affected by several factors, such as decreased blinking and low humidity in computer environments. Interestingly, MUC5AC was lower in the eye strain symptomatic group (P < .001) than in the asymptomatic group despite our finding that prolonged daily VDT use was not always associated with eye strain (Supplement [eTable 3]).
The major limitation of the present study is the difference in sample numbers among the groups. For example, the definite DED group was smaller than the probable and no DED groups. In fact, the data were not normally distributed. We did not identify how much this imbalanced data size affected the final result. To compensate for the biased sample, a sample size larger than found in the present study is needed.
Consequently, in our study, the mean MUC5AC concentration in the definite DED group was lower than that in the no DED group, although the mean Schirmer test I value was similar between the groups. Therefore, our findings suggest that the MUC5AC concentration in tears may contribute to the stability of the human tear film 33 and the low MUC5AC concentration in tears may increase stress and induce ocular discomfort.
Conclusions
Office workers with prolonged daily use of VDTs, as well as those with an increased frequency of eye strain, have significantly low MUC5AC concentrations in their tears. In addition, in the present study, MUC5AC concentration in the tears of patients with DED was lower than that in individuals without DED.
